Basics BioAge Labs, Inc. IPO Date: September 26, 2024 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $416.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.27% Avg Daily Range (30 D): $0.23 | 2.61% Avg Daily Range (90 D): $0.16 | 2.46% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .42M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 101 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 59 Avg Inst. Trade: $1.38M Avg Inst. Trade (30 D): $.57M Avg Inst. Trade (90 D): $.86M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $.59M Avg Closing Trade (90 D): $1.05M Avg Closing Volume: 258.2K     News Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries Nov 7, 2025 @ 2:00 PM BioAge Labs to Present at Jefferies Global Healthc... Source: Bioage Labs, Inc. Oct 26, 2025 @ 10:33 PM BioAge Labs Stock Just Soared. Does It Have More F... Source: Cory Renauer Aug 15, 2025 @ 1:00 PM BioAge Labs Announces First Participant Dosed in P... Source: Bioage Labs Aug 7, 2025 @ 3:14 AM BioAge Labs (BIOA) Q2 Revenue Hits $2.4M Source: Na Financials   TTM Q3 2025 Q2 2025 Basic EPS $13.61 $-.56 $-.6 Diluted EPS $13.61 $-.56 $-.6 Revenue $ 5.92M $ 2.05M $ 2.41M Gross Profit $ $ $ Net Income / Loss $ -75.79M $ -20.17M $ -21.56M Operating Income / Loss $ -89.72M $ -23.14M $ -24.77M Cost of Revenue $ $ $ Net Cash Flow $ -118.97M $ -4.75M $ -37.11M PE Ratio 0.87